Erlandson Kristine M, Li Xiuhong, Abraham Alison G, Margolick Joseph B, Lake Jordan E, Palella Frank J, Koletar Susan L, Brown Todd T
aUniversity of Colorado, Aurora, Colorado bJohns Hopkins University, Baltimore, Maryland cUniversity of California Los Angeles, Los Angeles, California dNorthwestern University, Chicago, Illinois eOhio State University, Columbus, Ohio, USA.
AIDS. 2016 Jan 28;30(3):445-54. doi: 10.1097/QAD.0000000000000932.
The long-term consequences of wasting among HIV-infected persons are not known.
HIV-infected men surviving ≥2 years based on Kaplan-Meier analysis after a clinical diagnosis or weight trajectory consistent with wasting and with available physical function assessment data [grip strength, gait speed, and quality of life (QoL)] were matched to HIV-infected and uninfected men without wasting.
Matching criteria at the functional assessment included age, calendar year, and CD4 T-cell count and plasma HIV-1 RNA (HIV-infected only). Multivariable linear regression analyses adjusted for age, cohort, race, hepatitis C status, and number of comorbid illnesses were used to assess the impact of wasting on subsequent physical function.
Among 85 HIV-infected men surviving ≥2 years after wasting, we evaluated physical function outcomes compared with 249 HIV-infected and 338 HIV-uninfected men with no historical wasting. In multivariable regression models, HIV-infected men with prior wasting had lower grip strength and poorer physical QoL than HIV-infected men with no wasting (P ≤ 0.03), and poorer physical QoL, but higher mental QoL than HIV-uninfected men (P ≤ 0.05). When controlling for measures of immune suppression (nadir CD4 T-cell count/AIDS, the association between wasting and physical QoL was markedly attenuated, whereas there was minimal impact on the association between wasting and grip strength.
HIV-infected wasting survivors had weaker grip strength compared with HIV-infected persons without wasting; immune suppression was associated only with physical QoL. HIV-infected survivors of wasting may represent a population of adults at increased risk for physical function decline.
HIV感染者消瘦的长期后果尚不清楚。
根据Kaplan-Meier分析,临床诊断或体重轨迹符合消瘦且有可用身体功能评估数据[握力、步速和生活质量(QoL)]的存活≥2年的HIV感染男性与未消瘦的HIV感染和未感染男性进行匹配。
功能评估的匹配标准包括年龄、年份、CD4 T细胞计数和血浆HIV-1 RNA(仅适用于HIV感染者)。采用多变量线性回归分析,对年龄、队列、种族、丙型肝炎状态和合并疾病数量进行调整,以评估消瘦对后续身体功能的影响。
在85名消瘦后存活≥2年的HIV感染男性中,我们评估了与249名无既往消瘦的HIV感染男性和338名未感染HIV男性相比的身体功能结果。在多变量回归模型中,既往消瘦的HIV感染男性的握力低于未消瘦的HIV感染男性,身体生活质量较差(P≤0.03),身体生活质量较差,但心理生活质量高于未感染HIV的男性(P≤0.05)。在控制免疫抑制指标(最低CD4 T细胞计数/艾滋病)时,消瘦与身体生活质量之间的关联明显减弱,而对消瘦与握力之间的关联影响最小。
与未消瘦的HIV感染者相比,HIV感染消瘦幸存者的握力较弱;免疫抑制仅与身体生活质量相关。HIV感染消瘦幸存者可能是身体功能下降风险增加的成年人群体。